Watchlist Price Alert

CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · Real-Time Price · USD

32.48

0.01 (0.03%)

At close: Mar 21, 2024, 8:00 PM

CymaBay Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-105.37M	-106M	-90M	-50.99M	-102.81M	-72.55M	-27.56M	-26.67M
Depreciation & Amortization	681K	710K	688K	632K	572K	105K	35K	29K
Stock-Based Compensation	15.23M	9.52M	10M	7.32M	10.47M	7.01M	4.92M	2.47M
Other Working Capital	2.9M	-895K	4.04M	681K	-4.44M	8.2M	120K	399K
Other Non-Cash Items	14.03M	14.03M	2.9M	-104K	910K	-115K	437K	476K
Deferred Income Tax	-2.73M	n/a	637K	n/a	-3.15M	1.75M	5.57M	50K
Change in Working Capital	5.63M	-2.34M	6.35M	-1.59M	-3.91M	8.86M	-3.04M	290K
Operating Cash Flow	-72.53M	-84.08M	-69.43M	-44.73M	-97.91M	-54.94M	-19.63M	-23.35M
Capital Expenditures	-445K	-148K	-87K	-21K	-315K	-529K	-27K	-42K
Cash Acquisitions	-7.86M	-874K	637K	-104K	-2.24M	-1.95M	-199K	n/a
Purchase of Investments	-305.67M	-174.98M	-78.08M	-176.3M	-290.89M	-276.38M	-98.39M	-22.91M
Sales Maturities Of Investments	219.55M	129.14M	126.76M	224.28M	256.86M	222.8M	30.88M	50.08M
Other Investing Acitivies	7.86M	874K	-637K	104K	2.24M	1.95M	199K	27.17M
Investing Cash Flow	-86.57M	-45.98M	48.59M	47.96M	-34.35M	-54.11M	-67.53M	27.13M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	345.77M	24.55M	118.45M	92K	108.13M	134.99M	99.72M	-986K
Financial Cash Flow	345.77M	24.55M	118.45M	92K	108.13M	134.99M	99.72M	-986K
Net Cash Flow	186.24M	-105.52M	97.61M	3.32M	-24.13M	25.94M	12.56M	2.79M
Free Cash Flow	-72.98M	-84.23M	-69.52M	-44.75M	-98.23M	-55.47M	-19.66M	-23.39M